Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the ATHN 2 Study
Author(s):
							Janna Journeycake, Dunlei Cheng, Tammuella Chrisentery-Singleton, Vidhi Desai, Annette von Drygalski, Carol Fedor, Nikki Hirsh, Birju Patel, Leslie J Raffini, Michael Recht, Robert F Sidonio Jr, Michael Wang, Xiang Zhang, Ellis J Neufeld						
				
							Publication:						
				
							Blood						
				
							Date:						
				
							November 23, 2021						
				
							Topics:						
				
							Dosing, Rix-FP, hemophilia B